CDEK
← All trials

NCT02951156

Phase 3Interventional

Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.

View on ClinicalTrials.gov ↗

Timeline

Start date
Dec 16, 2016
Primary completion
Feb 2, 2021
Completion date
May 29, 2021
First posted
—
Last posted
—
Enrollment
304
Arms / groups
5 / —
Source
AACT · pre-existing

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.